A

Alexion

Global biopharmaceuticals focusing on rare diseases

Quantitative Intern

Quantitative Biology & BiostatisticsPosted on Nov 12
Internship · Summer 2027Boston, MA, USA$48 /hr

About the Job

Requirements

  • Currently pursuing a PhD in Biostatistics, Statistics, or a related field.
  • Have completed two years of graduate work and passed the doctoral qualification exam before the internship starts.
  • Have an anticipated graduation date after August 2027.
  • Have U.S. work authorization at the time of application that does not require future sponsorship; OPT support is not provided.
  • Be familiar with statistical simulations and demonstrate the ability to conduct independent statistical research.
  • Have proficient programming skills in R and SAS.
  • Be able to report on site to Boston-Seaport, Massachusetts, three days per week; relocation assistance is not provided.
  • Have strong writing, communication, and interpersonal skills.

Responsibilities

  • Perform a literature review of Bayesian statistical methods, incorporating external evidence into the design of phase 3 studies.
  • Conduct a comprehensive simulation study to evaluate design characteristics under varying assumptions.
  • Present the internship work at a departmental seminar and write a final report of the internship project.

About the Company

Alexion

Global biopharmaceuticals focusing on rare diseases

Alexion, now the rare disease group within AstraZeneca, develops and sells therapies for rare and ultra-rare diseases by targeting the complement immune system. Its drugs, such as Soliris and Ultomiris, inhibit the C5 component to slow or stop disease processes, while Strensiq and Kanuma address specific metabolic disorders. It differentiates itself through a deep focus on complement biology, pursuing first- or best-in-class therapies, and using a strategy that blends internal R&D with acquisitions to expand its pipeline. Its goal is to improve outcomes for patients with rare diseases and bring these therapies to a broader international market using AstraZeneca’s scale and capabilities.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Boston, MA
Founded
1992

Recently Posted Jobs

Explore more opportunities at Alexion

See more jobs